OBJECTIVE: To characterize adiponectin protein complexes in lean and obese horses. ANIMALS: 26 lean horses and 18 obese horses. Procedures-Body condition score (BCS) and serum insulin activity were measured for each horse. Denaturing and native western blot analyses were used to evaluate adiponectin complexes in serum. A human ELISA kit was validated and used to quantify high-molecular weight (HMW) complexes. Correlations between variables were made, and HMW values were compared between groups. RESULTS: Adiponectin was present as a multimer consisting of HMW (> 720-kDa), low-molecular weight (180-kDa), and trimeric (90-kDa) complexes in serum. All complexes were qualitatively reduced in obese horses versus lean horses, but the percentage of complexes < 250 kDa was higher in obese versus lean horses. High-molecular weight adiponectin concentration measured via ELISA was negatively correlated with serum insulin activity and BCS and was lower in obese horses (mean ± SD, 3.6 ± 3.9 μg/mL), compared with lean horses (8.0 ± 4.6 μg/mL). CONCLUSIONS AND CLINICAL RELEVANCE: HMW adiponectin is measurable via ELISA, and concentration is negatively correlated with BCS and serum insulin activity in horses. A greater understanding of the role of adiponectin in equine metabolism will provide insight into the pathophysiology of metabolic disease conditions.
OBJECTIVE: To characterize adiponectin protein complexes in lean and obesehorses. ANIMALS: 26 lean horses and 18 obesehorses. Procedures-Body condition score (BCS) and serum insulin activity were measured for each horse. Denaturing and native western blot analyses were used to evaluate adiponectin complexes in serum. A human ELISA kit was validated and used to quantify high-molecular weight (HMW) complexes. Correlations between variables were made, and HMW values were compared between groups. RESULTS: Adiponectin was present as a multimer consisting of HMW (> 720-kDa), low-molecular weight (180-kDa), and trimeric (90-kDa) complexes in serum. All complexes were qualitatively reduced in obesehorses versus lean horses, but the percentage of complexes < 250 kDa was higher in obese versus lean horses. High-molecular weight adiponectin concentration measured via ELISA was negatively correlated with serum insulin activity and BCS and was lower in obesehorses (mean ± SD, 3.6 ± 3.9 μg/mL), compared with lean horses (8.0 ± 4.6 μg/mL). CONCLUSIONS AND CLINICAL RELEVANCE: HMW adiponectin is measurable via ELISA, and concentration is negatively correlated with BCS and serum insulin activity in horses. A greater understanding of the role of adiponectin in equine metabolism will provide insight into the pathophysiology of metabolic disease conditions.
Authors: S A Durward-Akhurst; N E Schultz; E M Norton; A K Rendahl; H Besselink; P A Behnisch; A Brouwer; R J Geor; J R Mickelson; M E McCue Journal: Chemosphere Date: 2018-11-26 Impact factor: 7.086
Authors: Caroline M M Loos; Kristine L Urschel; Eric S Vanzant; Erin L Oberhaus; Adam D Bohannan; James L Klotz; Kyle R McLeod Journal: Front Vet Sci Date: 2022-05-31
Authors: Nicholas J Bamford; Samantha J Potter; Courtnay L Baskerville; Patricia A Harris; Simon R Bailey Journal: J Vet Intern Med Date: 2018-12-05 Impact factor: 3.333
Authors: Andy E Durham; Nicholas Frank; Cathy M McGowan; Nicola J Menzies-Gow; Ellen Roelfsema; Ingrid Vervuert; Karsten Feige; Kerstin Fey Journal: J Vet Intern Med Date: 2019-02-06 Impact factor: 3.333
Authors: Ninja P Karikoski; Justin R Box; Anna K Mykkänen; Veikko V Kotiranta; Marja R Raekallio Journal: Equine Vet J Date: 2021-11-08 Impact factor: 2.692